<VariationArchive VariationID="450223" VariationName="NM_003239.5(TGFB3):c.886_893dup (p.Lys298fs)" VariationType="Duplication" Accession="VCV000450223" Version="7" RecordType="classified" NumberOfSubmissions="3" NumberOfSubmitters="3" DateLastUpdated="2024-07-29" DateCreated="2017-12-19" MostRecentSubmission="2024-05-01">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="445252" VariationID="450223">
      <GeneList>
        <Gene Symbol="TGFB3" FullName="transforming growth factor beta 3" GeneID="7043" HGNC_ID="HGNC:11769" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>14q24.3</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="14" Accession="NC_000014.9" start="75958097" stop="75983011" display_start="75958097" display_stop="75983011" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="14" Accession="NC_000014.8" start="76424441" stop="76448091" display_start="76424441" display_stop="76448091" Strand="-" />
          </Location>
          <OMIM>190230</OMIM>
        </Gene>
      </GeneList>
      <Name>NM_003239.5(TGFB3):c.886_893dup (p.Lys298fs)</Name>
      <CanonicalSPDI>NC_000014.9:75963348:TTCCTCTG:TTCCTCTGTTCCTCTG</CanonicalSPDI>
      <VariantType>Duplication</VariantType>
      <Location>
        <CytogeneticLocation>14q24.3</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="14" Accession="NC_000014.9" start="75963348" stop="75963349" display_start="75963348" display_stop="75963349" variantLength="8" positionVCF="75963348" referenceAlleleVCF="C" alternateAlleleVCF="CTTCCTCTG" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="14" Accession="NC_000014.8" start="76429691" stop="76429692" display_start="76429691" display_stop="76429692" variantLength="8" positionVCF="76429691" referenceAlleleVCF="C" alternateAlleleVCF="CTTCCTCTG" />
      </Location>
      <ProteinChange>K298fs</ProteinChange>
      <HGVSlist>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000014.8" sequenceAccession="NC_000014" sequenceVersion="8" change="g.76429692_76429699dup" Assembly="GRCh37">
            <Expression>NC_000014.8:g.76429692_76429699dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000014.9" sequenceAccession="NC_000014" sequenceVersion="9" change="g.75963349_75963356dup" Assembly="GRCh38">
            <Expression>NC_000014.9:g.75963349_75963356dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_011715.1" sequenceAccession="NG_011715" sequenceVersion="1" change="g.23394_23401dup">
            <Expression>NG_011715.1:g.23394_23401dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001329938.2" sequenceAccession="NM_001329938" sequenceVersion="2" change="c.886_893dup">
            <Expression>NM_001329938.2:c.886_893dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001316867.1" sequenceAccession="NP_001316867" sequenceVersion="1" change="p.Lys298fs">
            <Expression>NP_001316867.1:p.Lys298fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001329939.2" sequenceAccession="NM_001329939" sequenceVersion="2" change="c.886_893dup">
            <Expression>NM_001329939.2:c.886_893dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001316868.1" sequenceAccession="NP_001316868" sequenceVersion="1" change="p.Lys298fs">
            <Expression>NP_001316868.1:p.Lys298fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_003239.5" sequenceAccession="NM_003239" sequenceVersion="5" change="c.886_893dup" MANESelect="true">
            <Expression>NM_003239.5:c.886_893dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_003230.1" sequenceAccession="NP_003230" sequenceVersion="1" change="p.Lys298fs">
            <Expression>NP_003230.1:p.Lys298fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="LRG_399" sequenceAccession="LRG_399">
            <Expression>LRG_399:g.23394_23401dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_003239.2" sequenceAccession="NM_003239" sequenceVersion="2" change="c.886_893dupCAGAGGAA">
            <Expression>NM_003239.2:c.886_893dupCAGAGGAA</Expression>
          </NucleotideExpression>
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef ID="CA658656426" DB="ClinGen" />
        <XRef Type="rs" ID="1555360368" DB="dbSNP" />
      </XRefList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_003239.5(TGFB3):c.886_893dup (p.Lys298fs) AND not provided" Accession="RCV000521380" Version="8">
        <ClassifiedConditionList TraitSetID="9460">
          <ClassifiedCondition DB="MedGen" ID="C3661900">not provided</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2017-07-08" SubmissionCount="1">Likely pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_003239.5(TGFB3):c.886_893dup (p.Lys298fs) AND Familial thoracic aortic aneurysm and aortic dissection" Accession="RCV002314910" Version="9">
        <ClassifiedConditionList TraitSetID="7840">
          <ClassifiedCondition DB="MedGen" ID="C4707243">Familial thoracic aortic aneurysm and aortic dissection</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2021-04-04" SubmissionCount="1">Likely pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_003239.5(TGFB3):c.886_893dup (p.Lys298fs) AND Rienhoff syndrome" Accession="RCV003583166" Version="1">
        <ClassifiedConditionList TraitSetID="12483">
          <ClassifiedCondition DB="MedGen" ID="C3810012">Rienhoff syndrome</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2023-07-21" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2023-07-21" NumberOfSubmissions="3" NumberOfSubmitters="3" DateCreated="2017-12-19" MostRecentSubmission="2024-05-01">
        <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
        <Description>Pathogenic/Likely pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">25835445</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">31898322</ID>
        </Citation>
        <DescriptionHistory Dated="2024-02-11">
          <Description>Likely pathogenic</Description>
        </DescriptionHistory>
        <DescriptionHistory Dated="2022-11-28">
          <Description>Conflicting classifications of pathogenicity</Description>
        </DescriptionHistory>
        <DescriptionHistory Dated="2020-12-07">
          <Description>Likely pathogenic</Description>
        </DescriptionHistory>
        <DescriptionHistory Dated="2020-12-03">
          <Description>Conflicting classifications of pathogenicity</Description>
        </DescriptionHistory>
        <DescriptionHistory Dated="2018-04-13">
          <Description>Likely pathogenic</Description>
        </DescriptionHistory>
        <ConditionList>
          <TraitSet ID="12483" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="18469" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Loeys-Dietz syndrome 5</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">Rienhoff syndrome</ElementValue>
                <XRef ID="MONDO:0014262" DB="MONDO" />
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">LDS5</ElementValue>
                <XRef Type="MIM" ID="615582" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">RNHF</ElementValue>
                <XRef Type="MIM" ID="615582" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="12356" />
                <XRef ID="12356" DB="Office of Rare Diseases" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="public definition">Loeys-Dietz syndrome (LDS) is characterized by vascular findings (cerebral, thoracic, and abdominal arterial aneurysms and/or dissections), skeletal manifestations (pectus excavatum or pectus carinatum, scoliosis, joint laxity, arachnodactyly, talipes equinovarus, cervical spine malformation and/or instability), craniofacial features (widely spaced eyes, strabismus, bifid uvula / cleft palate, and craniosynostosis that can involve any sutures), and cutaneous findings (velvety and translucent skin, easy bruising, and dystrophic scars). Individuals with LDS are predisposed to widespread and aggressive arterial aneurysms and pregnancy-related complications including uterine rupture and death. Individuals with LDS can show a strong predisposition for allergic/inflammatory disease including asthma, eczema, and reactions to food or environmental allergens. There is also an increased incidence of gastrointestinal inflammation including eosinophilic esophagitis and gastritis or inflammatory bowel disease. Wide variation in the distribution and severity of clinical features can be seen in individuals with LDS, even among affected individuals within a family who have the same pathogenic variant.</Attribute>
                <XRef ID="NBK1133" DB="GeneReviews" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301312</ID>
                <ID Source="BookShelf">NBK1133</ID>
              </Citation>
              <Citation Type="practice guideline" Abbrev="NICE, 2020">
                <URL>https://www.nice.org.uk/guidance/ng156</URL>
                <CitationText>UK NICE Guideline NG156, Abdominal aortic aneurysm: diagnosis and management, 2020</CitationText>
              </Citation>
              <XRef ID="C3810012" DB="MedGen" />
              <XRef ID="MONDO:0014262" DB="MONDO" />
              <XRef Type="MIM" ID="615582" DB="OMIM" />
            </Trait>
          </TraitSet>
          <TraitSet ID="7840" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="16634" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Familial thoracic aortic aneurysm and aortic dissection</ElementValue>
                <XRef ID="MONDO:0019625" DB="MONDO" />
                <XRef ID="91387" DB="Orphanet" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Thoracic aortic aneurysms and dissections</ElementValue>
                <XRef ID="UWMG_7008129" DB="CSER _CC_NCGL, University of Washington" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Thoracic aortic aneurysm and aortic dissection</ElementValue>
                <XRef ID="Thoracic+Aortic+Aneurysms+and+Aortic+Dissections/9386" DB="Genetic Alliance" />
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">EDS</ElementValue>
              </Symbol>
              <Symbol>
                <ElementValue Type="Preferred">TAAD</ElementValue>
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="2249" />
                <XRef ID="2249" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301299</ID>
                <ID Source="BookShelf">NBK1120</ID>
              </Citation>
              <Citation Type="general" Abbrev="CCS, 2014">
                <ID Source="PubMed">24882528</ID>
              </Citation>
              <Citation Type="general" Abbrev="ESC, 2014">
                <ID Source="PubMed">25173340</ID>
              </Citation>
              <XRef ID="91387" DB="Orphanet" />
              <XRef ID="C4707243" DB="MedGen" />
              <XRef ID="MONDO:0019625" DB="MONDO" />
              <XRef Type="Phenotypic series" ID="PS607086" DB="OMIM" />
            </Trait>
          </TraitSet>
          <TraitSet ID="9460" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="17556" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">not provided</ElementValue>
                <XRef ID="13DG0619" DB="Department Of Translational Genomics (developmental Genetics Section), King Faisal Specialist Hospital &amp; Research Centre" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">none provided</ElementValue>
              </Name>
              <AttributeSet>
                <Attribute Type="public definition">The term 'not provided' is registered in MedGen to support identification of submissions to ClinVar for which no condition was named when assessing the variant. 'not provided' differs from 'not specified', which is used when a variant is asserted to be benign, likely benign, or of uncertain significance for conditions that have not been specified.</Attribute>
              </AttributeSet>
              <XRef ID="C3661900" DB="MedGen" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="1205188" SubmissionDate="2019-01-29" DateLastUpdated="2017-12-19" DateCreated="2017-12-19">
        <ClinVarSubmissionID localKey="GDX:1714166|Not Provided" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV000618776" DateUpdated="2017-12-19" DateCreated="2017-12-19" Type="SCV" Version="2" SubmitterName="GeneDx" OrgID="26957" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2017-07-08">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Likely pathogenic</GermlineClassification>
          <Comment>Although the c.886_893dupCAGAGGAA likely pathogenic variant in the TGFB3 gene has not been reported to our knowledge, this variant causes a shift in reading frame starting at codon lysine 298, changing it to an asparagine, and creating a premature stop codon at position 74 of the new reading frame, denoted p.Lys298AsnfsX74. This likely pathogenic variant is expected to result in either an abnormal, truncated protein product or loss of protein from this allele through nonsense-mediated mRNA decay. Other frameshift variants in the TGFB3 gene have been reported in Human Gene Mutation Database in association with TGFB3-related disorders (Stenson et al., 2014), indicating that loss of function is a mechanism of disease for this gene. Furthermore, the c.886_893dupCAGAGGAA variant has not been observed in large population cohorts (Lek et al., 2016; 1000 Genomes Consortium et al., 2015; Exome Variant Server).</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">GeneDx Variant Classification (06012015)</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/ft/byid/dhtz9flo/genedx_interprules_final_061215.pdf</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="TGFB3" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <Location>
            <SequenceLocation Assembly="GRCh37" Chr="14" alternateAllele="TTCCTCTGTTCCTCTG" referenceAllele="TTCCTCTG" start="76429691" stop="76429692" variantLength="2" />
          </Location>
          <AttributeSet>
            <Attribute Type="HGVS">NM_003239.2:c.886_893dupCAGAGGAA</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">Not Provided</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB5098196</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="1438391" SubmissionDate="2024-04-24" DateLastUpdated="2024-05-01" DateCreated="2018-04-14">
        <ClinVarSubmissionID localKey="a679069|MedGen:C4707243" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV000739727" DateUpdated="2024-05-01" DateCreated="2018-04-14" Type="SCV" Version="5" SubmitterName="Ambry Genetics" OrgID="61756" OrganizationCategory="laboratory" OrgAbbreviation="Ambry" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2021-04-04">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Likely pathogenic</GermlineClassification>
          <Comment>The c.886_893dupCAGAGGAA variant, located in coding exon 5 of the TGFB3 gene, results from a duplication of CAGAGGAA at nucleotide position 886, causing a translational frameshift with a predicted alternate stop codon (p.K298Nfs*74). This alteration is expected to result in loss of function by premature protein truncation or nonsense-mediated mRNA decay. While loss of function has not yet been clearly established as a mechanism of disease for TGFB3, alterations resulting in haploinsufficiency have been reported in patients with features consistent with manifestations of Loeys-Dietz syndrome (Schepers D et al. Hum Mutat. 2018;39(5):621-634; Ambry internal data). Based on the majority of available evidence to date, this variant is likely to be pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Ambry Variant Classification Scheme 2023</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/api/2.0/files/i9igeqse/ambry_variant_classification_scheme_2023.pdf/?format=attachment</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="TGFB3" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_003239.2:c.886_893dupCAGAGGAA</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C4707243" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>All AVA3 Novel and Update Variants_103122</SubmissionName>
          <SubmissionName>FinalClinVarSubmissionFile_20140101to20240315_ava3_1</SubmissionName>
          <SubmissionName>NonExomeUpdate_081220AmbryReport</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="8055579" SubmissionDate="2024-02-08" DateLastUpdated="2024-02-14" DateCreated="2024-02-14">
        <ClinVarSubmissionID localKey="5304511|MedGen:C3810012" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV004369394" DateUpdated="2024-02-14" DateCreated="2024-02-14" Type="SCV" Version="1" SubmitterName="Invitae" OrgID="500031" OrganizationCategory="laboratory" OrgAbbreviation="Invitae" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2023-07-21">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">25835445</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">31898322</ID>
          </Citation>
          <Comment>This sequence change creates a premature translational stop signal (p.Lys298Asnfs*74) in the TGFB3 gene. While this is not anticipated to result in nonsense mediated decay, it is expected to disrupt the last 115 amino acid(s) of the TGFB3 protein. This variant is not present in population databases (gnomAD no frequency). This variant has not been reported in the literature in individuals affected with TGFB3-related conditions. ClinVar contains an entry for this variant (Variation ID: 450223). This variant disrupts a region of the TGFB3 protein in which other variant(s) (p.Arg300Trp) have been determined to be pathogenic (PMID: 25835445, 31898322). This suggests that this is a clinically significant region of the protein, and that variants that disrupt it are likely to be disease-causing. For these reasons, this variant has been classified as Pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Invitae Variant Classification Sherloc (09022015)</Attribute>
          <Citation>
            <ID Source="PubMed">28492532</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="TGFB3" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000014.8:g.76429691_76429692insTTCCTCTG</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C3810012" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB14200283</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="1205188" TraitType="Disease" MappingType="Name" MappingValue="Not Provided" MappingRef="Preferred">
        <MedGen CUI="C3661900" Name="not provided" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="1438391" TraitType="Disease" MappingType="XRef" MappingValue="C4707243" MappingRef="MedGen">
        <MedGen CUI="C4707243" Name="Familial thoracic aortic aneurysm and aortic dissection" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="8055579" TraitType="Disease" MappingType="XRef" MappingValue="C3810012" MappingRef="MedGen">
        <MedGen CUI="C3810012" Name="Rienhoff syndrome" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

